Source: Υπουργείο Υγείας (CY) Revision Year: 2020 Publisher: Novartis Ireland Limited, Vista Building, Elm Park, Merrion Road, Dublin 4, Ireland <u>Marketing License Holder Representative in Cyprus:</u> Novartis Pharma Services Inc., Methonis Tower, 73 Arch. Makarios ...
CATAFLAM Sugar Coated Tablets 50mg.
| Pharmaceutical Form |
|---|
|
Sugar coated tablet. |
Each tablet contains 50 mg of diclofenac potassium.
Chemical name: Potassium-[o-[(2,6-dichlorophenyl)-amino]-phenyl]-acetate
Excipient(s) with known effect:
Sodium starch glycolate.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Diclofenac |
Diclofenac is a non-steroidal anti-inflammatory drug. The mechanism of action of diclofenac in AK may be related to the inhibition of the cycloxygenase pathway leading to reduced prostaglandin E2 (PGE2) synthesis. In addition, immunohistochemistry (IHC) from skin biopsies ac revealed that the clinical effects of diclofenac in AK are primarily due to anti-inflammatory, anti-angiogenic and possibly anti-proliferative effects and apoptosis-inducing mechanisms. |
| List of Excipients |
|---|
|
Silica, colloidal anhydrous (Aerosil 200) |
PVC/PE/PVDC blister strips containing 20 tablets.
(PVC 190-275 micron, PE20-40 micron, PVDC 32-59 micron, aluminium foil 26-34 micron).
Novartis Ireland Limited, Vista Building, Elm Park, Merrion Road, Dublin 4, Ireland
Marketing License Holder Representative in Cyprus:
Novartis Pharma Services Inc., Methonis Tower, 73 Arch. Makarios ΙΙΙ Avenue, 1070 Nicosia, Cyprus
P.O.Box 23917, 1687 Nicosia
18492
Date of first authorisation: 08 March 1991
Date of latest renewal: 26 September 2011
| Drug | Countries | |
|---|---|---|
| CATAFLAM | Albania, Brazil, Cyprus, Ecuador, Estonia, Hong Kong, Ireland, Israel, Lithuania, Malta, Mexico, Netherlands, Poland, Singapore, Tunisia, Turkey, South Africa |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
